Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Iatrogenic Pneumothorax Following Nasogastric Tube Misplacement.

Granados G, Ojanguren A, Ojanguren I.

Arch Bronconeumol. 2019 Oct 22. pii: S0300-2896(19)30115-2. doi: 10.1016/j.arbres.2019.03.004. [Epub ahead of print] English, Spanish. No abstract available.

2.

Cost-consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma.

Vallejo-Aparicio LA, Molina J, Ojanguren I, Viejo Casas A, Huerta A, Svedsater H.

Eur J Health Econ. 2019 Sep 23. doi: 10.1007/s10198-019-01101-x. [Epub ahead of print]

PMID:
31549255
3.

Addition of Rituximab to Oral Corticosteroids in the Treatment of Chronic Hypersensitivity Pneumonitis.

Morell F, Ojanguren I, Villar A, Ramon MA, Muñoz X, Cruz MJ.

Arch Bronconeumol. 2019 Sep 7. pii: S0300-2896(19)30315-1. doi: 10.1016/j.arbres.2019.07.013. [Epub ahead of print] English, Spanish. No abstract available.

4.

Impact of Low Dose Chlorine Inhalation in Healthy Humans: A Pilot Study.

Ojanguren I, Chaboillez S, Cloutier Y, Panariti A, McGovern TK, Martin JG, Lemiere C.

J Investig Allergol Clin Immunol. 2019;29(4):323-325. doi: 10.18176/jiaci.0396. Epub 2019 Apr 8. No abstract available.

5.

European Respiratory Society International Congress, Paris, 2018: highlights from the Clinical Assembly.

Vanfleteren LEGW, Ojanguren I, Nolan CM, Franssen FME, Andrianopoulos V, Grgic A, van Dijk M, Slebos DJ, Daines L, Kocks JWH, Kahn N.

ERJ Open Res. 2019 Feb 11;5(1). pii: 00176-2018. doi: 10.1183/23120541.00176-2018. eCollection 2019 Feb. Review.

6.

Diagnosis of occupational hypersensitivity pneumonitis.

Morell F, Ojanguren I, Cruz MJ.

Curr Opin Allergy Clin Immunol. 2019 Apr;19(2):105-110. doi: 10.1097/ACI.0000000000000511.

PMID:
30649011
7.

Long-term outcomes in chronic hypersensitivity pneumonitis.

Ojanguren I, Morell F, Ramón MA, Villar A, Romero C, Cruz MJ, Muñoz X.

Allergy. 2019 May;74(5):944-952. doi: 10.1111/all.13692. Epub 2019 Jan 13.

PMID:
30515826
8.

Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.

Clos-Parals A, Rodríguez-Martínez P, Cañete F, Mañosa M, Ruiz-Cerulla A, José Paúles M, Llaó J, Gordillo J, Fumagalli C, Garcia-Planella E, Ojanguren I, Cabré E, Guardiola J, Domènech E.

J Crohns Colitis. 2019 Mar 26;13(3):385-388. doi: 10.1093/ecco-jcc/jjy173.

PMID:
30346606
9.

High Resolution Computed Tomography and Fiberoptic Bronchoscopy in the Study of Severe Asthma.

Clofent D, Sansano I, Ojanguren I.

Arch Bronconeumol. 2018 Dec;54(12):627. doi: 10.1016/j.arbres.2018.05.018. Epub 2018 Jul 24. English, Spanish. No abstract available.

10.

Low blood eosinophil counts are not always a reliable marker of clinical response to mepolizumab in severe asthma.

Ojanguren I, Chaboillez S, Lemiere C.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2151-2153. doi: 10.1016/j.jaip.2018.04.014. Epub 2018 Apr 30. No abstract available.

PMID:
29715561
11.

Correction: Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma.

Ojanguren I, Moullec G, Hobeika J, Miravitlles M, Lemiere C.

PLoS One. 2018 Apr 4;13(4):e0195648. doi: 10.1371/journal.pone.0195648. eCollection 2018.

12.

The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up.

Muñoz X, Álvarez-Puebla MJ, Arismendi E, Arochena L, Ausín MDP, Barranco P, Bobolea I, Cañas JA, Cardaba B, Crespo A, Del Pozo V, Domínguez-Ortega J, Fernandez-Nieto MDM, Giner J, González-Barcala FJ, Luna JA, Mullol J, Ojanguren I, Olaguibel JM, Picado C, Plaza V, Quirce S, Ramos D, Rial M, Romero-Mesones C, Salgado FJ, San-José ME, Sánchez-Diez S, Sastre B, Sastre J, Soto L, Torrejón M, Urnadoz M, Valdes L, Valero A, Cruz MJ.

Arch Bronconeumol. 2018 Mar 19. pii: S0300-2896(18)30009-7. doi: 10.1016/j.arbres.2017.12.012. [Epub ahead of print] English, Spanish.

13.

Hypersensitivity Pneumonitis. Towards a Less Invasive Diagnostic Procedure.

Morell F, Ojanguren I, Cruz MJ.

Arch Bronconeumol. 2018 Sep;54(9):445-446. doi: 10.1016/j.arbres.2018.02.005. Epub 2018 Mar 16. English, Spanish. No abstract available.

14.

Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma.

Ojanguren I, Moullec G, Hobeika J, Miravitlles M, Lemiere C.

PLoS One. 2018 Mar 2;13(3):e0193144. doi: 10.1371/journal.pone.0193144. eCollection 2018. Erratum in: PLoS One. 2018 Apr 4;13(4):e0195648.

15.

CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78).

Aran G, Sanjurjo L, Bárcena C, Simon-Coma M, Téllez É, Vázquez-Vitali M, Garrido M, Guerra L, Díaz E, Ojanguren I, Elortza F, Planas R, Sala M, Armengol C, Sarrias MR.

FASEB J. 2018 Jul;32(7):3878-3891. doi: 10.1096/fj.201700941RR. Epub 2018 Feb 20.

PMID:
29465313
16.

High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study.

Caballería L, Pera G, Arteaga I, Rodríguez L, Alumà A, Morillas RM, de la Ossa N, Díaz A, Expósito C, Miranda D, Sánchez C, Prats RM, Urquizu M, Salgado A, Alemany M, Martinez A, Majeed I, Fabrellas N, Graupera I, Planas R, Ojanguren I, Serra M, Torán P, Caballería J, Ginès P.

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1138-1145.e5. doi: 10.1016/j.cgh.2017.12.048. Epub 2018 Feb 13.

17.

Chlorine Inhalation Challenge in Humans: Development of a New Closed-Circuit Methodology.

Ojanguren I, Cloutier Y, Chaboillez S, Lemiere C.

Arch Bronconeumol. 2018 Aug;54(8):440-442. doi: 10.1016/j.arbres.2017.11.005. Epub 2017 Dec 16. English, Spanish. No abstract available.

18.

Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.

Calafat M, Lobatón T, Hernández-Gallego A, Mañosa M, Torres P, Cañete F, Cabré E, Ojanguren I, Domènech E.

Dig Liver Dis. 2017 Dec;49(12):1327-1331. doi: 10.1016/j.dld.2017.08.041. Epub 2017 Sep 8.

PMID:
28958412
19.

Thymic Stromal Lymphopoietin: A Promising Target in the Treatment of Asthma?

Ojanguren I, Martin JG, Lemiere C.

Arch Bronconeumol. 2017 Oct;53(10):545-546. doi: 10.1016/j.arbres.2017.05.015. Epub 2017 Jun 20. English, Spanish. No abstract available.

20.

Effect of anti-IgE in occupational asthma caused by exposure to low molecular weight agents.

Ollé-Monge M, Cruz MJ, Gomez-Ollés S, Ojanguren I, Vanoirbeek J, Muñoz X.

Allergy. 2017 Nov;72(11):1720-1727. doi: 10.1111/all.13190. Epub 2017 Jul 20.

PMID:
28439933
21.

Specific inhalation challenge: the relationship between response, clinical variables and lung function.

Hu C, Cruz MJ, Ojanguren I, de Homdedeu M, Gonzalez-Barcala FJ, Munoz X.

Occup Environ Med. 2017 Aug;74(8):586-591. doi: 10.1136/oemed-2016-103806. Epub 2017 Mar 7.

PMID:
28270447
22.

My night on call in Spain.

Ojanguren I.

Breathe (Sheff). 2016 Sep;12(3):289-290. doi: 10.1183/20734735.011916.

23.

Comparative Effect of the I3.1 Probiotic Formula in Two Animal Models of Colitis.

Lorén V, Manyé J, Fuentes MC, Cabré E, Ojanguren I, Espadaler J.

Probiotics Antimicrob Proteins. 2017 Mar;9(1):71-80. doi: 10.1007/s12602-016-9239-5.

PMID:
27832441
24.

Do Low Molecular Weight Agents Cause More Severe Asthma than High Molecular Weight Agents?

Meca O, Cruz MJ, Sánchez-Ortiz M, González-Barcala FJ, Ojanguren I, Munoz X.

PLoS One. 2016 Jun 9;11(6):e0156141. doi: 10.1371/journal.pone.0156141. eCollection 2016.

25.

Anti-SRP auto-antibodies are not specific for myositis: Report of 8 cases.

Rodríguez-Muguruza S, Lozano-Ramos I, Coll-Canti J, Hernández-Gallego A, Ojanguren I, Martinez-Caceres E, Olive A.

Joint Bone Spine. 2017 Jan;84(1):103-105. doi: 10.1016/j.jbspin.2015.12.005. Epub 2016 May 25. No abstract available.

PMID:
27236258
26.

Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy.

Morell F, Villar A, Ojanguren I, Muñoz X, Cruz MJ.

Semin Respir Crit Care Med. 2016 Jun;37(3):395-405. doi: 10.1055/s-0036-1580692. Epub 2016 May 27. Review.

PMID:
27231863
27.

Utility of Exhaled Nitric Oxide Fraction for the Diagnosis of Hypersensitivity Pneumonitis.

Ojanguren I, Cruz MJ, Villar A, Barrecheguren M, Morell F, Muñoz X.

Lung. 2016 Feb;194(1):75-80. doi: 10.1007/s00408-015-9824-5. Epub 2015 Nov 13.

PMID:
26566790
28.

Changes in PH in exhaled breath condensate after specific bronchial challenge test in patients with chronic hypersensitivity pneumonitis: a prospective study.

Ojanguren I, Cruz MJ, Villar A, Sanchez-Ortiz M, Morell F, Munoz X.

BMC Pulm Med. 2015 Sep 30;15:109. doi: 10.1186/s12890-015-0100-5.

29.

Inhalation challenge in the differential diagnosis of usual interstitial pneumonia.

Muñoz X, Sanchez-Ortíz M, Ojanguren I, Cruz MJ.

Eur Respir Rev. 2015 Sep;24(137):542-4. doi: 10.1183/16000617.00000415. No abstract available.

30.

Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis.

Lorén V, Cabré E, Ojanguren I, Domènech E, Pedrosa E, García-Jaraquemada A, Mañosa M, Manyé J.

PLoS One. 2015 Jun 19;10(6):e0130921. doi: 10.1371/journal.pone.0130921. eCollection 2015.

31.

Incidence and Triggers of Asthma Exacerbations Attended in the Emergency Department as a Level of Care Indicator (ASMAB III, 2005 and ASMAB IV, 2011).

Ojanguren I, Genover T, Muñoz X, Ramon MA, Martínez Moragon E, Morell F.

Arch Bronconeumol. 2016 Feb;52(2):82-7. doi: 10.1016/j.arbres.2015.02.007. Epub 2015 Apr 22. English, Spanish.

32.

Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus?

Julián MT, Alonso N, Ojanguren I, Pizarro E, Ballestar E, Puig-Domingo M.

World J Diabetes. 2015 Mar 15;6(2):321-5. doi: 10.4239/wjd.v6.i2.321. Review.

33.

Nodular Mucinosis of the Breast in a Male: Reassessment of Diagnostic Criteria and Proposal for Its Classification as a Soft Tissue Tumor in the Myofibroblastoma and Spindle Cell Lipoma Spectrum.

Fernández-Figueras MT, Kazakov DV, López Martos R, Ojanguren I, Vila J, Ariza A.

Dermatopathology (Basel). 2014 Jul 1;1(1):47-54. doi: 10.1159/000364859. eCollection 2014 Jan-Jul.

34.

Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.

Sanmartín R, Tor J, Sanvisens A, López JJ, Jou A, Muga R, Ojanguren I, Barluenga E, Videla S, Planas R, Clotet B, Tural C.

HIV Med. 2014 Apr;15(4):203-12. doi: 10.1111/hiv.12105. Epub 2013 Nov 19.

35.

Two short interventions to reduce health care requirements in asthma patients. A multicentre controlled study (ASTHMACAP II).

Morell F, Ojanguren I, Cordovilla R, Urrutia I, Agüero R, Guerra J, Genover T, Ramon MA; ASMACAP Study Group.

Med Clin (Barc). 2014 Apr 22;142(8):348-54. doi: 10.1016/j.medcli.2013.01.051. Epub 2013 Aug 7.

PMID:
23932566
36.

Biomarkers for diagnosis and monitoring of celiac disease.

Vives-Pi M, Takasawa S, Pujol-Autonell I, Planas R, Cabre E, Ojanguren I, Montraveta M, Santos AL, Ruiz-Ortiz E.

J Clin Gastroenterol. 2013 Apr;47(4):308-13. doi: 10.1097/MCG.0b013e31827874e3. Review.

PMID:
23388848
37.

Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.

Sanmartin R, de Felipe E, Tor J, Sanvicens A, Barluenga E, Martinez E, Muga R, Jou A, Ojanguren I, López JJ, Clotet B, Tural C.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1235-43. Epub 2012 Apr 20.

PMID:
22443303
38.

Bacteria and spontaneous experimental colitis: immunological changes.

Pedrosa E, Lorén V, Cabré E, Doménech E, Ojanguren I, Gassull MA, Mañé J.

Eur J Clin Invest. 2011 Oct;41(10):1047-53. doi: 10.1111/j.1365-2362.2011.02499.x. Epub 2011 Mar 9.

PMID:
21902690
39.

Therapeutic effect of antisecretory factor-rich egg yolk on the late phases of 2,4,6-trinitrobenzenesulphonic acid colitis in mice.

Mañé J, Lorén V, Pedrosa E, Ojanguren I, Domènech E, Gassull MA, Cabré E.

Br J Nutr. 2011 Nov;106(10):1522-8. doi: 10.1017/S0007114511002042. Epub 2011 Jul 1.

PMID:
21733301
40.

Idiopathic myointimal hyperplasia of mesenteric veins and pneumatosis intestinalis: a previously unreported association.

García-Castellanos R, López R, de Vega VM, Ojanguren I, Piñol M, Boix J, Domènech E, Cabré E.

J Crohns Colitis. 2011 Jun;5(3):239-44. doi: 10.1016/j.crohns.2010.12.003. Epub 2011 Jan 13.

PMID:
21575888
41.

Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice.

Mañé J, Lorén V, Pedrosa E, Ojanguren I, Xaus J, Cabré E, Domènech E, Gassull MA.

Inflamm Bowel Dis. 2009 Aug;15(8):1155-63. doi: 10.1002/ibd.20908.

PMID:
19266568
42.

Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.

Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R.

J Viral Hepat. 2009 Jul;16(7):513-8. doi: 10.1111/j.1365-2893.2009.01103.x. Epub 2009 Feb 5.

PMID:
19200132
43.

Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.

Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, Clotet B.

Clin Gastroenterol Hepatol. 2009 Mar;7(3):339-45. doi: 10.1016/j.cgh.2008.11.019. Epub 2008 Dec 3.

PMID:
19171202
44.

Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice.

Mañé J, Pedrosa E, Lorén V, Ojanguren I, Fluvià L, Cabré E, Rogler G, Gassull MA.

J Nutr. 2009 Mar;139(3):603-10. doi: 10.3945/jn.108.101170. Epub 2009 Jan 6.

PMID:
19126671
45.

Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models.

Cáceres N, Tapia G, Ojanguren I, Altare F, Gil O, Pinto S, Vilaplana C, Cardona PJ.

Tuberculosis (Edinb). 2009 Mar;89(2):175-82. doi: 10.1016/j.tube.2008.11.001. Epub 2008 Dec 24.

PMID:
19110471
46.

Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy.

Domènech E, Vega R, Ojanguren I, Hernández A, Garcia-Planella E, Bernal I, Rosinach M, Boix J, Cabré E, Gassull MA.

Inflamm Bowel Dis. 2008 Oct;14(10):1373-9. doi: 10.1002/ibd.20498.

PMID:
18452205
47.

Reduced liver injury in the interleukin-6 knockout mice by chronic carbon tetrachloride administration.

Río A, Gassull MA, Aldeguer X, Ojanguren I, Cabré E, Fernández E.

Eur J Clin Invest. 2008 May;38(5):306-16. doi: 10.1111/j.1365-2362.2008.01939.x. Epub 2008 Mar 26.

PMID:
18371088
48.

Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis.

Alonso N, Granada ML, Salinas I, Reverter JL, Flores L, Ojanguren I, Martínez-Cáceres EM, Sanmartí A.

Eur J Endocrinol. 2007 Dec;157(6):763-9.

PMID:
18057384
49.

Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.

Miquel M, Soler A, Vaqué A, Ojanguren I, Costa J, Planas R.

Liver Int. 2007 Oct;27(8):1144-7.

PMID:
17845544
50.

Collagenous duodeno-ileo-colitis with transient IgG deficiency preceded by Yersinia enterocolitica intestinal infection: case report and review of literature.

Navarro-Llavat M, Domènech E, Masnou H, Ojanguren I, Mañosa M, Lorenzo-Zúñiga V, Boix J, Gassull MA.

Gastroenterol Hepatol. 2007 Apr;30(4):219-21. Review.

PMID:
17408550

Supplemental Content

Loading ...
Support Center